In the present study, we sought to further elucidate the complex molecular underpinnings of a previously unreported interaction between PRMT5 and YBX1 and how it relates to NF-κB, with the goal of uncovering novel therapeutic avenues for CRC. Here, YBX1 is linked to colorectal carcinoma.